Home/Filings/5/0001829126-25-000544
5//SEC Filing

Owens David 5

Accession 0001829126-25-000544

CIK 0001527352other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 5:26 PM ET

Size

6.9 KB

Accession

0001829126-25-000544

Insider Transaction Report

Form 5
Period: 2024-12-31
Owens David
DirectorChief Medical Officer
Transactions
  • Purchase

    Common stock

    2024-12-20$2.75/sh+1,000$2,750149,293 total
  • Award

    Stock Option (right to buy)

    2024-11-07+262,500262,500 total
    Exercise: $0.94From: 2024-11-07Exp: 2029-08-26Common Stock (262,500 underlying)

Issuer

Nexalin Technology, Inc.

CIK 0001527352

Entity typeother

Related Parties

1
  • filerCIK 0001916664

Filing Metadata

Form type
5
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:26 PM ET
Size
6.9 KB